NCT00384137View on ClinicalTrials.gov

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Transplantation
Interventions
DRUG

Tacrolimus

Immunosuppression

Trial Locations (13)

6229

Maastricht

28034

Madrid

28041

Madrid

79106

Freiburg im Breisgau

93053

Regensburg

94275

Bicêtre

3015 GD

Rotterdam

60-479

Poznan

70-111

Szczecin

08025

Barcelona

08036

Barcelona

08916

Barcelona

M13 9WL

Manchester

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00384137 - A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients | Biotech Hunter | Biotech Hunter